Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Serina Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 38 | 35 | −3 |
| Shares | 5.07M | 4.82M | −243.9K (−4.8%) |
| Value | $8.21M | $7.48M | −$732.1K (−8.9%) |
New holders (2)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 26,861 | $42.0K | 0.00% |
| Albion Financial Group | 304 | $0 | 0.00% |
Sold out (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Millennium Management LLC | 18,523 | $30.0K |
| Iowa State Bank | 11,000 | $18.0K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 3,000 | $4.00K |
| Atlas Private Wealth Management | 525 | $1.00K |
| Eudaimonia Partners, LLC | 50 | $0 |